Shionogi will receive $375 million to develop a long-acting protease inhibitor designed to prevent SARS-CoV-2 infection in ...

Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...

Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) ...

Catalyst’s approach builds on the company’s unique protease engineering platform, which can generate improved or novel molecules to help correct disease-causing imbalances in the complement ...

Researchers from Kumamoto University have identified a liver-derived protein, serine protease inhibitor A1 (SerpinA1), as a ...

A multiplex drug screening platform with cellular biosensors identifies antivirals against 40 diverse viruses simultaneously.

Request To Download Free Sample of This Strategic Report @ Vietnam Protease Market unique selling proposition covered repots: This comprehensive study delves into the thriving landscape of the ...

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immuno ...

They are called carbohydrase enzymes, protease enzymes and lipase enzymes. Carbohydrates found in starchy and sugary foods are an important source of energy in a healthy diet. When you chew ...

Chimerix submitted a new drug application to the FDA seeking accelerated approval for dordaviprone to treat patients with ...

They are called carbohydrase enzymes, protease enzymes and lipase enzymes. Carbohydrates found in starchy and sugary foods are an important source of energy in a healthy diet. When you chew ...